Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001570562-24-000119
Filing Date
2024-09-04
Accepted
2024-09-04 16:14:51
Documents
1
Period of Report
2024-08-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1725480877.html 4  
1 FORM 4 wk-form4_1725480877.xml 4 3568
  Complete submission text file 0001570562-24-000119.txt   5046
Mailing Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660
Business Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660 (949) 284-4555
Evolus, Inc. (Issuer) CIK: 0001570562 (see all company filings)

EIN.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 520 NEWPORT CENTER DRIVE, SUITE 1200 NEWPORT BEACH CA 92660
Business Address
Yamagishi-Dressler Tomoko (Reporting) CIK: 0001990968 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38381 | Film No.: 241277771